Andrew Slimmon, Morgan Stanley Investment Management senior portfolio manager, joins 'Squawk Box' to discuss the latest ...
The stock market remains volatile. After opening in the green on December 10th, the market declined. Meanwhile, a global ...
Morgan Stanley says it's bullish on medtech in 2025 and upgraded Intuitive Surgical (ISRG), Tandem (TNDM), Stryker (SYK), ...
European stocks and US futures struggled for direction as political upheaval in the Middle East and South Korea tempered ...
The S&P 500 has delivered a median return of +1.5% during this month over the past 45 years, with positive results occurring ...
In this piece, we will take a look at Morgan Stanley’s top cyclical stocks for an economic recovery. As 2024 approaches its end, the stock market has been through it all. The driving theme of ...
Global shares turned lower on Monday as traders focused on U.S. inflation data and chip stocks fell, while Beijing's promise ...
It’s extremely difficult to predict short-term moves in the market with any accuracy. But the research, analysis, and ...
Morgan Stanley upgraded State Street (STT) to Overweight from Equal Weight with a price target of $139, up from $102. The end of quantitative ...
In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on C4 Therapeutics (CCCC – Research Report). The ...
Morgan Stanley analyst Keith Weiss noted that cybersecurity remains a top spending priority for organizations globally.